Methylphenidate Hydrochloride 30 mg/1

Methylphenidate Hydrochloride 30 mg/1 is an extended-release capsule used to manage certain conditions. This medication is designed for oral administration and is manufactured by Actavis Pharma, Inc. in the USA.

Methylphenidate Hydrochloride 30 mg/1 is commonly used to help manage symptoms of attention deficit hyperactivity disorder (ADHD). It is also prescribed for narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. The extended-release formulation is designed to provide a prolonged effect, helping users maintain focus and reduce impulsivity throughout the day. Users often ask, 'What is methylphenidate hydrochloride used for?' and the primary uses include improving concentration and managing symptoms of ADHD.

Methylphenidate Hydrochloride 30 mg/1 may cause common effects such as decreased appetite, dry mouth, and insomnia. Some users may experience headaches or stomach discomfort. The extended-release formulation is designed to minimize fluctuations in drug levels, which can help reduce the severity of side effects. It is important to note that individual responses to the medication can vary.

Methylphenidate Hydrochloride 30 mg/1 should be handled with care and stored in a cool, dry place away from children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Users should be aware of potential side effects and consult a healthcare provider if they experience any severe or persistent symptoms.

Methylphenidate Hydrochloride 30 mg/1 may interact with certain medications, including antidepressants, blood pressure medications, and other stimulants. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol and other central nervous system depressants should be avoided while using this medication.